ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
London-based Isomorphic Labs raised $5 billion in Series C funding on November 17, 2026, to advance AI-powered drug discovery. This single deal accounted for roughly 75% of the nine dollar-denominated financings in the daily startup news roundup, highlighting investor focus on specific technologies over broad startup availability.
Tap to vote and see what everyone thinks.
Summary by ByteBrief